The case revolves around two Pakistani pharmaceutical companies, Berlex and Danas, that allegedly used political connections to obtain huge amounts of ephedrine and are suspected of diverting it to people in the drug trade who could have used it to make meth worth billions of dollars. The companies have denied any wrongdoing, The Dawn reported.
Ali Musa Gillani and 10 others were indicted by a special anti-narcotics court in the scandal.
Despite those accused maintaining their innocence, the judge formally charged the high-profile suspects of culpability in the ephedrine scandal.
Ex-chief justice Iftikhar Chaudhry had pointed out in early 2012 that Ali Musa was also a suspect in the case.
The Anti-Narcotics Force (ANF) then issued a notice to Musa Gillani and one of his alleged 'front men' for manipulating the unauthorised allocation.
In June of the same year, just as President Asif Ali Zardari nominated Makhdoom Shahabuddin as the PPP candidate for the prime minister after Yousaf Raza Gillani was removed by a court order, the ANF issued arrest warrants in his name. Consequently, Makhdoom Shahab could no longer be PPP's prime ministerial candidate.
The next hearing has been scheduled for May 12, in which the accused are expected to present their arguments.
Ephedrine, along with pseudoephedrine, is one of the main ingredients in methamphetamine, a scheduled narcotic substance.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
